AMBU A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.2 DKK | -1.10% |
|
+8.91% | +23.76% |
| 05-15 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
| 05-14 | Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024 |
Presenter SpeechUnknown Executive (Executives)[Interpreted] A warm welcome to Ambu's ordinary ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows:
- single-use endoscopes (56.3%);
- emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers;
- monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid.
At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico.
Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Calendar
2024-08-30
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
130.2
DKK
Average target price
111.2
DKK
Spread / Average Target
-14.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.76% | 5.05B | |
| -5.43% | 181B | |
| +4.30% | 114B | |
| -3.09% | 68.29B | |
| +5.86% | 52.24B | |
| +8.15% | 44.3B | |
| +7.52% | 42.73B | |
| +25.54% | 32.52B | |
| +17.85% | 26.02B | |
| +1.00% | 25.91B |
- Stock Market
- Equities
- AMBU B Stock
- News Ambu A/S
- Transcript : Ambu A/S - Shareholder/Analyst Call